Zions Bancorporation’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $18.8K | Buy |
178
+29
| +19% | +$3.11K | ﹤0.01% | 517 |
|
|
2024
Q3 | $16.1K | Sell |
149
-38
| -20% | -$4.15K | ﹤0.01% | 546 |
|
|
2024
Q2 | $20.3K | Sell |
187
-26
| -12% | -$3.06K | ﹤0.01% | 548 |
|
|
2024
Q1 | $28.1K | Hold |
213
| – | – | ﹤0.01% | 501 |
|
|
2023
Q4 | $25.9K | Buy |
213
+2
| +0.9% | +$223 | ﹤0.01% | 498 |
|
|
2023
Q3 | $23.7K | Sell |
211
-4
| -2% | -$508 | ﹤0.01% | 483 |
|
|
2023
Q2 | $31.3K | Hold |
215
| – | – | ﹤0.01% | 454 |
|
|
2023
Q1 | $27.8K | Hold |
215
| – | – | ﹤0.01% | 492 |
|
|
2022
Q4 | $27.4K | Hold |
215
| – | – | ﹤0.01% | 528 |
|
|
2022
Q3 | $22K | Buy |
215
+1
| +0.5% | +$110 | ﹤0.01% | 540 |
|
|
2022
Q2 | $22K | Buy |
214
+18
| +9% | +$2.14K | ﹤0.01% | 594 |
|
|
2022
Q1 | $25K | Buy |
196
+43
| +28% | +$5.18K | ﹤0.01% | 640 |
|
|
2021
Q4 | $19K | Sell |
153
-140
| -48% | -$18.3K | ﹤0.01% | 631 |
|
|
2021
Q3 | $42K | Buy |
293
+138
| +89% | +$20.3K | ﹤0.01% | 476 |
|
|
2021
Q2 | $24K | Sell |
155
-2
| -1% | -$324 | ﹤0.01% | 553 |
|
|
2021
Q1 | $24K | Sell |
157
-24
| -13% | -$3.72K | ﹤0.01% | 547 |
|
|
2020
Q4 | $27K | Buy |
181
+3
| +2% | +$424 | ﹤0.01% | 502 |
|
|
2020
Q3 | $23K | Hold |
178
| – | – | ﹤0.01% | 515 |
|
|
2020
Q2 | $21K | Sell |
178
-13
| -7% | -$1.5K | ﹤0.01% | 490 |
|
|
2020
Q1 | $19K | Sell |
191
-239
| -56% | -$31.3K | ﹤0.01% | 472 |
|
|
2019
Q4 | $63K | Sell |
430
-373
| -46% | -$51.5K | 0.01% | 380 |
|
|
2019
Q3 | $107K | Buy |
803
+20
| +3% | +$2.58K | 0.02% | 329 |
|
|
2019
Q2 | $90K | Sell |
783
-14
| -2% | -$1.64K | 0.01% | 315 |
|
|
2019
Q1 | $99K | Sell |
797
-79
| -9% | -$8.98K | 0.02% | 308 |
|
|
2018
Q4 | $89K | Sell |
876
-486
| -36% | -$54.7K | 0.07% | 132 |
|
|
2018
Q3 | $174K | Sell |
1,362
-219
| -14% | -$26K | 0.04% | 189 |
|
|
2018
Q2 | $171K | Sell |
1,581
-1,809
| -53% | -$197K | 0.12% | 101 |
|
|
2018
Q1 | $359K | Buy |
+3,390
| New | +$394K | 0.08% | 88 |
|
|
2017
Q4 | – | Sell |
-3,375
| Closed | -$384K | – | 992 |
|
|
2017
Q3 | $384K | Buy |
3,375
+205
| +6% | +$23.7K | 0.06% | 185 |
|
|
2017
Q2 | $395K | Buy |
3,170
+3,077
| +3,309% | +$365K | 0.07% | 115 |
|
|
2017
Q1 | $11K | Sell |
93
-81
| -47% | -$9.18K | ﹤0.01% | 359 |
|
|
2016
Q4 | $18K | Buy |
174
+32
| +23% | +$3.43K | ﹤0.01% | 401 |
|
|
2016
Q3 | $19K | Hold |
142
| – | – | ﹤0.01% | 387 |
|
|
2016
Q2 | $17K | Hold |
142
| – | – | ﹤0.01% | 368 |
|
|
2016
Q1 | $16K | Sell |
142
-22
| -13% | -$2.13K | ﹤0.01% | 442 |
|
|
2015
Q4 | $16K | Buy |
164
+14
| +9% | +$1.37K | ﹤0.01% | 415 |
|
|
2015
Q3 | $15K | Buy |
150
+124
| +477% | +$12.4K | ﹤0.01% | 412 |
|
|
2015
Q2 | $3K | Sell |
26
-100
| -79% | -$11.1K | ﹤0.01% | 245 |
|
|
2015
Q1 | $14K | Buy |
+126
| New | +$14.4K | ﹤0.01% | 456 |
|
Other funds holding ZBH
Zions Bancorporation's ZBH Position: Q4 2024 in Review
Zions Bancorporation increased its Zimmer Biomet (ZBH) stake by 19% in Q4 2024, buying an estimated $3.11K and bringing the position to 178 shares worth $18.8K. The position accounts for ﹤0.01% of the portfolio, ranked #517.
Zions Bancorporation first reported a position in ZBH in Q1 2015 and has held it in 39 quarters since. The position peaked at $395K in Q2 2017. 1,028 funds tracked by Wall St. Rank hold ZBH as of Q4 2024.
- Zions Bancorporation held 178 shares of Zimmer Biomet worth $18.8K as of Q4 2024.
- Zions Bancorporation bought 29 Zimmer Biomet shares in Q4 2024, an estimated $3.11K.
- Zimmer Biomet made up ﹤0.01% of Zions Bancorporation's portfolio in Q4 2024, its #517 holding.
- Zions Bancorporation first reported a position in Zimmer Biomet in Q1 2015 and has held it in 39 quarters since.
- Zions Bancorporation's Zimmer Biomet position peaked at $395K in Q2 2017.
- 1,028 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2024.
Based on Zions Bancorporation's 13F filing for Q4 2024, filed 11 Feb 2025.